ABSTRACT
The aim of this study was to determine the incidence of surgical site infections [SSI] in patients undergoing a Caesarean section [CS] and to identify risk factors, common bacterial pathogens and antibiotic sensitivity. SSI significantly affect the patients quality of life by increasing morbidity and extending hospital stays. A retrospective cross-sectional study was conducted in Nizwa Hospital, Oman, to determine the incidence of post-Caesarean [PCS] SSI from 2001 to 2012. This was followed by a case-control study of 211 PCS cases with SSL Controls [220] were randomly selected cases, at the same hospital in the same time period, who had undergone CS without any SSL Data was collected on CS type, risk factors, demographic profile, type of organism, drug sensitivity and date of infection. The total number of PCS wound infections was 211 [2.66%]. There was a four-fold higher incidence of premature rupture of the membranes [37, 17.53%] and a three-fold higher incidence of diabetes [32, 15.16%] in the PCS cases compared with controls. The most common organisms responsible for SSI were Staphylococcus aureus [66, 31.27%] and the Gram-negative Escherichia coli group [40, 18.95%]. The most sensitive antibiotics were aminoglycoside and cephalosporin. Polymicrobial infections were noted in 42 [19.90%], while 47 [22.27%] yielded no growth. A high incidence of associated risk factors like obesity, hypertension, anaemia and wound haematoma was noted. Measures are recommended to reduce the incidence of SSI, including the implementation of infection prevention practices and the administration of antibiotic prophylaxis with rigorous surgical techniques
ABSTRACT
Uterus didelphys with obstructed hemivagina and ipsilateral renal agenesis [OHVIRA Syndrome] is a rare congenital anomaly of the female genital tract. Uterus didelphys occurs when the midline fusion of the mullerian ducts is arrested, either completely or incompletely. Women with didelphic uterus may be asymptomatic and unaware of having a double uterus. They may present with complaints of dysmenorrhoea and dyspareunia. A 25 year old woman attending the infertility clinic at Nizwa regional referral hospital presented with history of dysmenorrhoea and foul vaginal discharge with right cystic pelvic mass. She was diagnosed as a case of double uterus with obstructed right hemivagina and right pyocolpos with ipsilateral renal agenesis after routine ultrasonography in the clinic followed by MRI. Excision of the right vaginal septum with drainage of 200 ml of purulent discharge was performed. She was relieved of her symptoms and conceived promptly after the surgical excision of the partial vaginal septum
Subject(s)
Humans , Female , Congenital Abnormalities , Kidney Diseases/congenital , Kidney/abnormalities , Dysmenorrhea , Vagina/abnormalitiesABSTRACT
Ectopic pregnancy occurs when the embryo fails to implant within the uterine cavity. Methotrexate, a folic acid antagonist has been widely used to treat ectopic pregnancy. The aim of this study is to determine the efficacy of methotrexate treatment for ectopic pregnancies in our settings which will in-turn help us reduce maternal mortality and morbidity. This was a retrospective review of 60 cases of ectopic pregnancy treated with single dose methotrexate in Nizwa hospital, Oman. Demographic data, clinical presentation, treatment progress, outcome, side effects and future fertility follow up were analysed using a computer database. Selection criteria included hemodynamically stable women with beta-hcg level of = 5000 mIU/ ml, adnexal mass = 4 cm, absent cardiac activity and hemoperitoneum less than 100 ml. Human chorionic gonadotrophin [hcg] assay and clinical presentation were used to determine cases which warranted surgical intervention. The success rate of single dose methotrexate therapy in our study was 65% [n=39] and 35% [n=21] required surgical intervention compared to reported success rate of 67-100% published in various studies. Careful selection of cases and confining strictly to the criteria improved the success rate from 40% to 60% in five and half years of the study. The mean average time of resolution of ectopic pregnancy was 32 days for a single dose and 58 days for repeat second or third doses. Eight cases of pregnancy of unknown location were treated successfully with methotrexate. No major side effects were noted. A successful fertility outcome of 30% in the first year followed by 13.3% in the subsequent second year with a secondary infertility rate of 11.65 was observed in this study. Methotrexate treatment of ectopic pregnancies is safe and effective with no major side effects. Intramuscular methotrexate has the advantage of tubal conservation and saves patients from requiring surgery. It is easier to administer than intraoperative route, which is by laparoscopy and needs expertise. Our study showed single dose methotrexate to be an effective treatment option for selected patients with unruptured tubal ectopic pregnancy
Subject(s)
Humans , Female , Pregnancy, Ectopic/surgery , Pregnancy , Methotrexate , Review Literature as Topic , Fallopian Tubes , Chorionic Gonadotropin , Maternal Age , Gestational Age , Retrospective StudiesABSTRACT
Unicornuate uterus with rudimentary horn is a rare type of uterine malformation associated with obstetrical complications. Rupture of pregnant rudimentary horn is the usual presentation resulting in severe haemoperitoneum with increased maternal morbidity, and at times, mortality. A case of ruptured rudimentary horn pregnancy in a 24-year-old, second gravida, is reported. Exploratory laparotomy revealed a ruptured rudimentary horn pregnancy of 14 weeks gestation with haemoperitoneum. Excision of the rudimentary horn was done and an uneventful recovery followed